Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Lennartsson

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|November 4, 2006
Alix facilitates the interaction between c-Cbl and platelet-derived growth factor beta-receptor and thereby modulates receptor down-regulationJohan Lennartsson, Piotr Wardega, Ulla Engström, et al.
Cellular Signalling|February 9, 2010
Erk 5 is necessary for sustained PDGF-induced Akt phosphorylation and inhibition of apoptosisJohan Lennartsson, Fatima Burovic, Barbara Witek, et al.
The Journal of Biological Chemistry|December 25, 2008
Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activationAleksandra Jurek, Kenichi Amagasaki, Agnieszka Gembarska, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 9, 2024
Cellular responses to silencing of PDIA3 (protein disulphide-isomerase A3): Effects on proliferation, migration, and genes in control of active vitamin DDespoina Kermpatsou, Frida Olsson, Erik Wåhlén, et al.
Biochemical and Biophysical Research Communications|May 10, 2023
Activated EGFR and PDGFR internalize in separate vesicles and downstream AKT and ERK1/2 signaling are differentially impacted by cholesterol depletionErik Wåhlén, Frida Olsson, Doroteya Raykova, et al.
Biochemical and Biophysical Research Communications|October 24, 2024
Crosstalk between 1,25(OH)<sub>2</sub>-Vitamin D<sub>3</sub> and the growth factors EGF and PDGF-BB: Impact on CYP24A1 expression and cell proliferationFrida Olsson, Erik Wåhlén, Johan Heldin, et al.
BMC Research Notes|November 4, 2017
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cellsLinda Sooman, Joachim Gullbo, Michael Bergqvist, et al.
International Journal of Oncology|September 1, 2011
The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell linesSara Häggblad Sahlberg, Diana Spiegelberg, Johan Lennartsson, et al.
Biochemical and Biophysical Research Communications|September 19, 2019
Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent mannerRunting Yin, Glenda Eger, Niki Sarri, et al.
Experimental Cell Research|April 11, 2019
Dynamin inhibitors impair platelet-derived growth factor β-receptor dimerization and signalingJohan Heldin, Marie Rubin Sander, Mattias Leino, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|November 4, 2006
Alix facilitates the interaction between c-Cbl and platelet-derived growth factor beta-receptor and thereby modulates receptor down-regulationJohan Lennartsson, Piotr Wardega, Ulla Engström, et al.
Cellular Signalling|February 9, 2010
Erk 5 is necessary for sustained PDGF-induced Akt phosphorylation and inhibition of apoptosisJohan Lennartsson, Fatima Burovic, Barbara Witek, et al.
The Journal of Biological Chemistry|December 25, 2008
Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced Erk activationAleksandra Jurek, Kenichi Amagasaki, Agnieszka Gembarska, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 9, 2024
Cellular responses to silencing of PDIA3 (protein disulphide-isomerase A3): Effects on proliferation, migration, and genes in control of active vitamin DDespoina Kermpatsou, Frida Olsson, Erik Wåhlén, et al.
Biochemical and Biophysical Research Communications|May 10, 2023
Activated EGFR and PDGFR internalize in separate vesicles and downstream AKT and ERK1/2 signaling are differentially impacted by cholesterol depletionErik Wåhlén, Frida Olsson, Doroteya Raykova, et al.
Biochemical and Biophysical Research Communications|October 24, 2024
Crosstalk between 1,25(OH)<sub>2</sub>-Vitamin D<sub>3</sub> and the growth factors EGF and PDGF-BB: Impact on CYP24A1 expression and cell proliferationFrida Olsson, Erik Wåhlén, Johan Heldin, et al.
BMC Research Notes|November 4, 2017
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cellsLinda Sooman, Joachim Gullbo, Michael Bergqvist, et al.
International Journal of Oncology|September 1, 2011
The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell linesSara Häggblad Sahlberg, Diana Spiegelberg, Johan Lennartsson, et al.
Biochemical and Biophysical Research Communications|September 19, 2019
Dual specificity phosphatase (DUSP)-4 is induced by platelet-derived growth factor -BB in an Erk1/2-, STAT3- and p53-dependent mannerRunting Yin, Glenda Eger, Niki Sarri, et al.
Experimental Cell Research|April 11, 2019
Dynamin inhibitors impair platelet-derived growth factor β-receptor dimerization and signalingJohan Heldin, Marie Rubin Sander, Mattias Leino, et al.
Pageof 8